SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Fleming ID, Phillips JL, Menck HR, Murphy GP, Winchester DP. The National Cancer Data Base report on recent hospital cancer program progress toward complete American Joint Committee on Cancer/TNM staging. Cancer. 1997; 80: 2305-2310.
  • 2
    American Joint Committee on Cancer. What is Cancer Staging? Available at: http://www.cancerstaging.org/mission/whatis.html. Accessed April 20, 2010.
  • 3
    EdgeSB, ByrdDR, ComptonCC, FritzAG, GreeneFL, TrottiA, eds. AJCC Cancer Staging Manual. 7th ed. New York: Springer; 2010.
  • 4
    Partin AW, Yoo J, Carter HB, et al. The use of prostate specific antigen, clinical stage and Gleason score to predict pathological stage in men with localized prostate cancer. J Urol. 1993; 150: 110-114.
  • 5
    Stephenson AJ, Scardino PT, Eastham JA, et al. Preoperative nomogram predicting the 10-year probability of prostate cancer recurrence after radical prostatectomy. J Natl Cancer Inst. 2006; 98: 715-717.
  • 6
    Shariat SF, Karakiewicz PI, Roehrborn CG, Kattan MW. An updated catalog of prostate cancer predictive tools. Cancer. 2008; 113: 3075-3099.
  • 7
    Reese AC, Cooperberg MR, Carroll PR. Minimal impact of clinical stage on prostate cancer prognosis among contemporary patients with clinically localized disease. J Urol. 2010; 184: 114-119.
  • 8
    Armatys SA, Koch MO, Bihrle R, Gardner TA, Cheng L. Is it necessary to separate clinical stage T1c from T2 prostate adenocarcinoma? BJU Int. 2005; 96: 777-780.
  • 9
    Billis A, Magna LA, Watanabe IC, Costa MV, Telles GH, Ferreira U. Are prostate carcinoma clinical stages T1c and T2 similar ? Int Braz J Urol. 2006; 32: 165-171.
  • 10
    Cooperberg MR, Pasta DJ, Elkin EP, et al. The University of California, San Francisco Cancer of the Prostate Risk Assessment score: a straightforward and reliable preoperative predictor of disease recurrence after radical prostatectomy. J Urol. 2005; 173: 1938-1942.
  • 11
    Campbell T, Blasko J, Crawford ED, et al. Clinical staging of prostate cancer: reproducibility and clarification of issues. Int J Cancer. 2001; 96: 198-209.
  • 12
    Sexton T, Rodrigues G, Brecevic E, et al. Controversies in prostate cancer staging implementation at a tertiary cancer center. Can J Urol. 2006; 13: 3327-3334.
  • 13
    Cooperberg MR, Broering JM, Litwin MS, et al. The contemporary management of prostate cancer in the United States: lessons from the cancer of the prostate strategic urologic research endeavor (CapSURE), a national disease registry. J Urol. 2004; 171: 1393-1401.
  • 14
    Lubeck DP, Litwin MS, Henning JM, et al. The CaPSURE database: a methodology for clinical practice and research in prostate cancer. CaPSURE Research Panel. Cancer of the Prostate Strategic Urologic Research Endeavor. Urology. 1996; 48: 773-777.
  • 15
    Cookson MS, Aus G, Burnett AL, et al. Variation in the definition of biochemical recurrence in patients treated for localized prostate cancer: the American Urological Association Prostate Guidelines for Localized Prostate Cancer Update Panel report and recommendations for a standard in the reporting of surgical outcomes. J Urol. 2007; 177: 540-545.
  • 16
    Eisenberg ML, Cowan JE, Davies BJ, Carroll PR, Shinohara K. The importance of tumor palpability and transrectal ultrasonographic appearance in the contemporary clinical staging of prostate cancer [published online ahead of print April 10, 2009.] Urol Oncol.
  • 17
    Ward JF, Slezak JM, Blute ML, Bergstralh EJ, Zincke H. Radical prostatectomy for clinically advanced (cT3) prostate cancer since the advent of prostate-specific antigen testing: 15-year outcome. BJU Int. 2005; 95: 751-756.
  • 18
    Cooperberg MR, Lubeck DP, Mehta SS, Carroll PR. Time trends in clinical risk stratification for prostate cancer: implications for outcomes (data from CaPSURE). J Urol. 2003; 170: S21-S25; discussion S26-S27.
  • 19
    Gosselaar C, Kranse R, Roobol MJ, Roemeling S, Schroder FH. The interobserver variability of digital rectal examination in a large randomized trial for the screening of prostate cancer. Prostate. 2008; 68: 985-993.
  • 20
    Coelho RF, Chauhan S, Orvieto MA, Palmer KJ, Rocco B, Patel VR. Predictive factors for positive surgical margins and their locations after robot-assisted laparoscopic radical prostatectomy [published online ahead of print February 15, 2009.] Eur Urol.
  • 21
    Walsh P, Partin A. Anatomic radical retropubic prostatectomy. In: WeinA, KavoussiL, NovickA, PartinA, PetersC, eds. Campbell-Walsh Urology. 9th ed. Philadelphia: Saunders Elsevier; 2007: 2956-2978.